ASSOCIATION OF LIPID PROFILES WITH 10-YEAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK: STUDY AMONG SUBJECTS IN SLEMAN DISTRICT OF YOGYAKARTA INDONESIA
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i12.20675Keywords:
Atherosclerotic cardiovascular disease, 10-year atherosclerotic cardiovascular disease risk, lipid profiles, cholesterol, ratio totalcholesterol high-density lipoprotein-cholesterol-C, ratio low-density lipoprotein-cholesterolhigh-density lipoprotein-chAbstract
Â
 Objectives: The subjects in the Sleman District of Yogyakarta had medium Framingham risk score (FRS) in the preceding year study. The 10-year atherosclerotic cardiovascular disease (ASCVD) risk was a newer risk estimator than FRS. This study aimed to associate the lipid profiles with the ASCVD risk.
Methods: The study was conducted with a cross-sectional design and the subjects were selected with cluster random sampling. The association of lipid profiles and ASCVD risk was analyzed with Mann–Whitney/Kruskal–Wallis tests and Spearman's rho correlation, whereas the categorical scores within sub-groups were analyzed Chi-square statistics, respectively.
Results: The eligible subjects (n=221) had the age at 51.7±8.1 years, systolic/diastolic blood pressure 136.8±22.4/85.0±12.4 mmHg, total-cholesterol (total-C), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), and triglyceride at 202.0±34.9 mg/dl, 52.6±12.5 mg/dl, 126.3±30.0 mg/dl, and 135.9±95.4 mg/dl, respectively; with hypertension treatment 16.7%, smoking 52.9%, diabetes 10.4%, and the median ASCVD risk at 4.4 (0.2-41.4). The ASCVD risk has significant association with non-lipid profiles, total-C, lipid ratio of triglyceride/HDL-C, total-C/HDL-C, and LDL-C/HDL-C, to a lesser extent, HDL-C, LDL-C, and triglyceride.
Conclusion: The 10-year ASCVD risk of the subjects was categorized as low and had a significant association with total-C and lipid ratio of triglyceride/ HDL-C, total-C/HDL-C, and LDL-C/HDL-C.
Downloads
References
Smith SC, Collins A, Ferrari R, Holmes DR, Logstrup S, McGhie DV, et al. WHF/AHA/ACCF/EHN/ESC presidential advisory our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). J Am Coll Cardiol 2012;60:2343-8.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. European guidelines on cardiovascular disease prevention in clinical practice; The 6 6th joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;37:2315-81.
Guerra-Silva NM, Santucci FS, Moreira RC, Massao Tashima C, de Melo SC, Pereira LR, et al. Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham. Int J Cardiol 2017;228:481-7.
NCEP-ATP III. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the 3rd report of the national Cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001;285(19):2486-97.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American college of cardiology/American Heart Association task force on practice guidelines. Circulation 2014;129 25 Suppl 2:S1-45.
Goff DC, Llyod-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American Heart Association task force on practice guidelines. Circulation 2013;00:000.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidemias. Eur Heart J 2016;37(39):2999-3058.
Chia YC, Lim HM, Ching SM. Validation of the pooled cohort risk score in an Asian population - A retrospective cohort study. BMC Cardiovasc Disord 2014;14:163.
American College of Cardiology (ACC). ASCVD Risk Estimator; 2016. Available from: http://www.tools.acc.org/ASCVD-Risk-estimator/. [Last accessed on 2017 Mar 10].
Preiss D, Kristensen SL. The new pooled cohort equations risk calculator. Can J Cardiol 2015;31(5):613-9.
Cook NR, Ridker PM. Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease; An update. Ann Intern Med 2016;165:786-94.
Suhadi R, Linawati Y, Virginia DM, Setiawan CH. Early implementation of universal health coverage among hypertension subjects in Sleman district of Yogyakarta. Acta Med Indones 2015;47(4):311-9.
Suhadi R, Linawati Y, Wulandari ET, Virginia DM, Setiawan CH. The metabolic disorder and cardiovascular risk among lower socioeconomic subjects in Yogyakarta - Indonesia. Asian J Pharm Clin Res 2017;10:367-2.
Gerstman B. Stat Primer (Version 7.0). Cha. 14. Correlation; 2016. Available from: http://www.sjsu.edu/faculty/gerstman/StatPrimer/correlation.pdf. [Last accessed on 2017 Mar 20]
Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999;99(9):1165-72.
Ameer KA, Mohammed SI. The Correlation between Framingham risk score and the clinical and biochemical parameters that measure functional disability and disease activity in Iraqi patients with rheumatoid arthritis. Int J Pharm Pharm Sci 2014;6:284-386.
Mancia G, Fargard R, Narkiewicz K, Redȯn J, Zanchetti A, BÈhm M, et al. ESH/ESC guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31(7):1281-357.
Bays HE, Chapman RH, Grandy S. SHIELD investigators’ group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidemia: Comparison of data from two national surveys. Int J Clin Pract 2007;61(5):737-47.
Gupta R, Misra A, Vikram NK, Kondal D, Gupta SS, Agrawal A, et al. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc Disord 2009;9:28.
Mortensen MB, Nordestgaard BG, Afzal S, Falk E. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: The copenhagen general population study. Eur Heart J 2017;38:586-94.
Ayuttaya KS, Ayuttaya SS. Cost-effectiveness analysis of statin monotherapy regimen in outpatient management of dyslipidemia in patients with diabetes mellitus. Songklanakarin J Sci Technol 2014;36(6):675-81.
Dhaliwali C, Erinmacpherson, Richardson J. Effectiveness of telephone-delivered interventions for increasing physical activity levels in persons with Type 2 diabetes or hypertension: A systematic review. J Crit Rev 2015;2(4):6-11.
Virani P, Sojitra R, Raj H, Vineet J. A review on Irbesartan co administered with atorvastatin for the treatment of cardiac risk. J Crit Rev 2014;1:25-8.
da Luz PL, Favarato D, Faria-Neto Jr JR, Lemos P, Chagas AC. High ratio of triglycerides to HDL-cholesterol ratio predicts extensive coronary disease. Clin Sci 2008;63(4):427-32.
Ridker PM, Cook NR. The pooled cohort equations 3 years on buiding a stronger foundation. Circulation 2016;134(23):1789-1.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
